These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 5727879)

  • 21. [Penicillamine in the therapy of progressive polyarthritis. (2 initial therapeutic attempts with small doses of penicillamine hydrochloride and base)].
    Truhlár P
    Fysiatr Revmatol Vestn; 1972 Jul; 50(3):149-57. PubMed ID: 5064182
    [No Abstract]   [Full Text] [Related]  

  • 22. [Treatment of common rheumatoid polyarthritis with D-penicillamine].
    Camus JP; Bénichou C; Guillien P; Crouzet J; Lièvre JA
    Rev Rhum Mal Osteoartic; 1971 Dec; 38(12):809-20. PubMed ID: 5152714
    [No Abstract]   [Full Text] [Related]  

  • 23. [Early recognition of adverse effects, especially of kidney lesions, in patients with progressive chronic polyarthritis under D-Penicillamine therapy].
    Otto W; Pietruschka WD; Beenken O
    Z Gesamte Inn Med; 1975 Aug; 30(15):507-9. PubMed ID: 1189496
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Penicillamine metal chelates and their possible importance in rheumatoid arthritis--a brief review.
    Davis P
    Clin Invest Med; 1984; 7(1):41-4. PubMed ID: 6723123
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Comparative studies on the immunodepressive effect of D-penicillamine and gold salts in chronic progressive polyarhtritis].
    Miehlke K; Kohlhardt I; Wirth B
    Z Rheumaforsch; 1968 Dec; 27(11):445-54. PubMed ID: 5710880
    [No Abstract]   [Full Text] [Related]  

  • 26. [D-penicillamine therapy of chronic polyarthritis].
    Günther R; Gabl F; Knapp E
    Z Rheumaforsch; 1973; 32(7):313-25. PubMed ID: 4741805
    [No Abstract]   [Full Text] [Related]  

  • 27. Effects of D-penicillamine on inflammatory and immune reactions.
    Harth M; Keown PA; Orange JF
    Clin Invest Med; 1984; 7(1):45-51. PubMed ID: 6723124
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The serum copper level and the therapeutic effect of D-penicylamine in patients with rheumatoid arthritis (author's transl)].
    Rudy J; Sarosiek J; Borejszo I
    Przegl Lek; 1978; 35(12):879-83. PubMed ID: 734155
    [No Abstract]   [Full Text] [Related]  

  • 29. [100 cases of common rheumatoid polyarthritis, treated with D-penicillamin].
    Camus JP; Crouzet J; Guillien P; Benichou C; Lievre JA
    Ann Med Interne (Paris); 1974 Jan; 125(1):9-28. PubMed ID: 4603018
    [No Abstract]   [Full Text] [Related]  

  • 30. [Experiences in the treatment of chronic polyarthritis using D-penicillamine].
    Miehlke K
    Verh Dtsch Ges Rheumatol; 1976; 4():464-9. PubMed ID: 997827
    [No Abstract]   [Full Text] [Related]  

  • 31. [Actual results of the rheumatoid polyarthritis therapy with immuno-suppressive drugs: d-penicillamine and cytostatics (author's transl)].
    Barnes CG
    Schweiz Rundsch Med Prax; 1977 Nov; 66(44):1412-20. PubMed ID: 928306
    [No Abstract]   [Full Text] [Related]  

  • 32. [Penicillamine D in primary chronic polyarthritis. A long-term study].
    Hadidi T
    Med Welt; 1976 Feb; 27(7):333-6. PubMed ID: 1256297
    [No Abstract]   [Full Text] [Related]  

  • 33. [Long-term treatment of chronic progredient polyarthritis with D-penicillamine].
    Hagemann D; Frankl R
    Med Welt; 1969 Aug; 35():1920-3. PubMed ID: 5809869
    [No Abstract]   [Full Text] [Related]  

  • 34. [Changes in various humoral immunity indicators during the treatment of rheumatoid arthritis with D-penicillamine (cuprenil)].
    Chwalińska-Sadowska H; Małdykowa H; Zajaczek-Grabowska A; Dratwianka B; Abgarowicz-Miłkowska T; Swierczyńska Z; Orłowska G; Rdułtowska H; Luft S; Rogozińska E
    Reumatologia; 1981; 19(2):151-7. PubMed ID: 6459630
    [No Abstract]   [Full Text] [Related]  

  • 35. Blood levels and side-effects of D-penicillamine.
    Van Der Korst JK; Muijsers AO; Henrichs AM; Ament HJ; Van De Stadt RJ
    Agents Actions Suppl; 1979; (5):159-67. PubMed ID: 294133
    [No Abstract]   [Full Text] [Related]  

  • 36. [Mode of action of D-penicillamine in chronic polyarthritis. 1. Protein synthesis inhibition in synovial fluid cells].
    Bröll H; Altmann H; Kocsis R; Tausch G
    Z Rheumatol; 1978; 37(1-2):51-5. PubMed ID: 629096
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Current status of D-penicillamine therapy in chronic polyarthritis].
    Franke M; Menning H; Ströbel G
    Z Rheumatol; 1981; 40(2):54-61. PubMed ID: 7282106
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Collagenolytic enzymes of the skin in chronic polyarthritis - transformations during D-penicillamin therapy].
    Kolarz G; Braun F; Menzel J; Scherak O
    Z Rheumatol; 1981; 40(1):37-9. PubMed ID: 7223081
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical experiences in the use of the synthetic D-Penicillamine Trolovol in the treatment of chronic polyarthritis].
    Strätz M; Meyer W
    Med Welt; 1974 Nov; 25(47):1992-5. PubMed ID: 4431329
    [No Abstract]   [Full Text] [Related]  

  • 40. Controlled multicenter trial of tiopronin and d-penicillamine for rheumatoid arthritis.
    Pasero G; Pellegrini P; Ambanelli U; Ciompi ML; Colamussi V; Ferraccioli G; Barbieri P; Mazzoni MR; Menegale G; Trippi D
    Arthritis Rheum; 1982 Aug; 25(8):923-9. PubMed ID: 7115451
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.